Most Clicked StoriesMore >


Report: Value of U.S. pharmaceutical market to hit nearly $550B in 5 years

BIO SmartBrief | Mar 20, 2015

A GlobalData report shows that the U.S. pharmaceutical industry will be worth $548 billion by 2020, compared with $395 billion last year. The anticipated market growth will be spurred by factors such as higher health care spending, increasing rates of lifestyle-related chronic diseases and easily accessible reimbursement for drug costs. PMLive.com (U.K.) (03/19)


Takeda Pharmaceutical, ImmunoGen sign licensing agreement

BIO SmartBrief | Mar 24, 2015

Biotech apples, potatoes receive FDA approval

BIO SmartBrief | Mar 23, 2015

European Commission OKs Novo Nordisk's liraglutide injection for obesity

BIO SmartBrief | Mar 25, 2015

Eli Lilly, Innovent Biologics sign 10-year cancer drug deal

BIO SmartBrief | Mar 23, 2015

Analysis: Global market for type 1 diabetes treatment to grow to $13.6B by 2023

BIO SmartBrief | Mar 23, 2015

HHS funds late-stage trial of Emergent's improved anthrax vaccine

BIO SmartBrief | Mar 25, 2015

Bill would speed up FDA's review of EU-approved drugs

BIO SmartBrief | Mar 23, 2015

Blueprint Medicines to file initial public offering

BIO SmartBrief | Mar 24, 2015

Treeway receives orphan drug designation for ALS treatment

BIO SmartBrief | Mar 25, 2015


Find BIO SmartBrief Issues by Date:



BIO News More >


Faster & better connections with quality R&D vendors

BIO SmartBrief | Mar 26, 2015

Industrial biotechnology with a French twist!

BIO SmartBrief | Mar 25, 2015

Savings on environmental waste disposal services

BIO SmartBrief | Mar 24, 2015

Secure document sharing services optimized for life science organizations

BIO SmartBrief | Mar 23, 2015

Registration is open for the BIO Asia International Conference!

BIO SmartBrief | Mar 20, 2015




Sign up for BIO SmartBrief



Designed specifically for biotechnology industry professionals like you, BIO SmartBrief is a FREE daily e-mail newsletter. It provides the latest news and information you need to stay informed about important biotech issues. Learn more